buthionine sulfoximine has been researched along with antimony in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akiyama, S; Chen, ZS; Furukawa, T; Haraguchi, M; Mutoh, M; Sumizawa, T; Tani, A | 1 |
| Goyal, N; Gupta, S; Mittal, MK; Rai, S; Sundar, S | 1 |
| Goyeneche-Patino, DA; Saravia, NG; Valderrama, L; Walker, J | 1 |
| Kneifel, C; Lösler, S; Rojewski, MT; Schlief, S; Schrezenmeier, H; Thiel, E | 1 |
| Comini, MA; Fonseca, MS; Moreira, DS; Murta, SM; Resende, BV; Santi, AM; Zoboli, AP | 1 |
| Almeida, RP; Bomfim, LG; Borges, VM; Corrêa, CB; Cruz, GS; Jesus, AR; Lipscomb, MW; Magalhães, LS; Mota, SG; Moura, TR; Tanajura, DM | 1 |
6 other study(ies) available for buthionine sulfoximine and antimony
| Article | Year |
|---|---|
Reversal of heavy metal resistance in multidrug-resistant human KB carcinoma cells.
Topics: Adenosine Triphosphate; Antimony; Antimony Potassium Tartrate; Arsenic; ATP-Binding Cassette Transporters; Buthionine Sulfoximine; Cyclic P-Oxides; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Inhibitors; Glutamate-Cysteine Ligase; Glutathione; Glutathione Transferase; Humans; KB Cells; Metals, Heavy; Multidrug Resistance-Associated Proteins; Nicotinic Acids | 1997 |
Characterization of natural antimony resistance in Leishmania donovani isolates.
Topics: Animals; Antimony; Antiprotozoal Agents; Buthionine Sulfoximine; Cells, Cultured; Drug Resistance; Gene Expression Regulation; Humans; Leishmania donovani; Leishmaniasis, Visceral; Sulfhydryl Compounds | 2007 |
Antimony resistance and trypanothione in experimentally selected and clinical strains of Leishmania panamensis.
Topics: Animals; Antimony; Antiprotozoal Agents; Buthionine Sulfoximine; Drug Resistance; Glutathione; Humans; Leishmania; Leishmaniasis; Parasitic Sensitivity Tests; Spermidine | 2008 |
Antimony-trioxide- and arsenic-trioxide-induced apoptosis in myelogenic and lymphatic cell lines, recruitment of caspases, and loss of mitochondrial membrane potential are enhanced by modulators of the cellular glutathione redox system.
Topics: Antimony; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Buthionine Sulfoximine; Caspase Inhibitors; Caspases; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Glutathione; HL-60 Cells; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, T-Cell; Membrane Potential, Mitochondrial; Neoplasm Proteins; Oxidation-Reduction; Oxides | 2009 |
Ornithine decarboxylase or gamma-glutamylcysteine synthetase overexpression protects Leishmania (Vianna) guyanensis against antimony.
Topics: Animals; Antimony; Blotting, Western; Buthionine Sulfoximine; Eflornithine; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Glutamate-Cysteine Ligase; Inhibitory Concentration 50; Leishmania guyanensis; Leishmaniasis, Mucocutaneous; Neglected Diseases; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitors; Rabbits; Recombinant Proteins | 2017 |
Increased thiol levels in antimony-resistant Leishmania infantum isolated from treatment-refractory visceral leishmaniasis in Brazil.
Topics: Antimony; Buthionine Sulfoximine; Drug Resistance; Enzyme Inhibitors; Humans; Leishmania infantum; Leishmaniasis, Visceral; Microscopy, Electron, Transmission; Parasitic Sensitivity Tests; Sulfhydryl Compounds | 2018 |